Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 12, 2016 12:35 PM ET

Biotechnology

Company Overview of Opus Bio, Inc.

Key Executives for Opus Bio, Inc.

NameBoard RelationshipsTitleAge
Tim Ravenscroft 4 RelationshipsChief Executive Officer and Director--
Yung Nien Chang Ph.d.No RelationshipsVice President of Vector Development--
Kathy Schonely No RelationshipsDirector of Quality Control--
Mohammed Zuber Ph.d.No RelationshipsDirector of Research & Development--

Opus Bio, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David S. Wetherell Ph.D. 30 RelationshipsGBP Capital60
Tim Ravenscroft 4 RelationshipsOpus Bio, Inc.--
John A. McMullen J.D., MBA 4 RelationshipsOpus Bio, Inc.72
Barrie J. Carter Ph.D. 18 RelationshipsBEAT BioTherapeutics Corp.70
Douglas D. Lind M.D. 13 RelationshipsTMune Therapeutics, Inc.--
View All Board Members

Opus Bio, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
330.7K
Bonus
221.9K
Total Short Term Compensation
417.9K
Total Value of Options
14.8M
Compensation as of Fiscal Year
Opus Bio, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Wausau Paper Corp. Announces Management Changes
January 22, 2016 8:10 PM ET
Spectrum Brands Holdings, Inc. Appoints David M. Maura as Executive Chairman
January 21, 2016 11:30 AM ET
Peter Harf Intends to Step Down from the Board of Reckitt Benckiser Group plc
December 21, 2015 7:00 AM ET
Blue Power Group Limited Appoints Catherine K. Goodall as Director to the Board
December 05, 2015 12:00 AM ET
Procter & Gamble Co. Announces Executive Changes
November 20, 2015 11:57 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Opus Bio, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.